<DOC>
	<DOCNO>NCT01645254</DOCNO>
	<brief_summary>The main objective study pharmacokinetics , pharmacodynamics tolerability decoction aerial part Argemone mexicana ( AM ) , administer healthy volunteer .</brief_summary>
	<brief_title>Phase 1b Malaria Clinical Trial Using Argemone Mexicana Healthy Adults Mali</brief_title>
	<detailed_description>This open non comparative safety pharmacokinetic ( PK ) study clinical trial . Healthy volunteer age 18 50 year old recruit follow 42 day treatment initiation current World Health Organization malaria drug protocol efficacy assessment protocol . Each volunteer take oral Argemone mexicana decoction formulation . For PK assessment purpose , 3 group constitute : ( ) group receive unique dose blood withdrawal schedule 0 hour , 30 minute , 1 hour , 2 hour , 4 hour , 6 hour , 8 hour 12 hour . ( ii ) group receive two dos ( morning evening ) Argemone mexicana 14 day blood withdrawal schedule 0 hour , 30 minute , 1 hour , 2 hour , 4 hour , 6 hour , 8 hour , 12 hour , 24 hour , 3 day , 7 day 14 day . ( iii ) group receive two dos ( morning evening ) Argemone mexicana 14 day blood withdrawal schedule 0 hour , 12 hour , 14 hour , 16 hour , 18 hour , 20 hour , 22 hour , 24 hour , 3 day , 7 day , 14 day 21 day Safety assess clinically ( Clinical exam Electrocardiography ) biologically ( hematology biochemistry parameter measure ) throughout 42 day thefollow-up .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>age 1850 year old ; good general health ; available duration study ; agreement participate study resident village know study ; acceptance conservation laboratory specimens future research . Plasmodium falciparum infection clinical manifestation ; Presence severe complicate malaria ; Acute medical condition ; Any medical condition require medical attention inconsistent study interfere study ; Severe medical condition ; Allergy product study , Pregnant woman nurse Taking derivative product study know antimalarial within 14 day enrollment . Refusal participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>malaria</keyword>
	<keyword>Argemone mexicana</keyword>
</DOC>